482 related articles for article (PubMed ID: 11069460)
1. Finasteride increases anagen hair in men with androgenetic alopecia.
Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
[TBL] [Abstract][Full Text] [Related]
2. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
Kaufman KD; Olsen EA; Whiting D; Savin R; DeVillez R; Bergfeld W; Price VH; Van Neste D; Roberts JL; Hordinsky M; Shapiro J; Binkowitz B; Gormley GJ
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
[TBL] [Abstract][Full Text] [Related]
3. Effects of finasteride (1 mg) on hair transplant.
Leavitt M; Perez-Meza D; Rao NA; Barusco M; Kaufman KD; Ziering C
Dermatol Surg; 2005 Oct; 31(10):1268-76, discussion 1276. PubMed ID: 16188178
[TBL] [Abstract][Full Text] [Related]
4. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD
J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
[TBL] [Abstract][Full Text] [Related]
5. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
Price VH; Menefee E; Sanchez M; Kaufman KD
J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
[TBL] [Abstract][Full Text] [Related]
6. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women.
Whiting DA; Waldstreicher J; Sanchez M; Kaufman KD
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):282-4. PubMed ID: 10674382
[TBL] [Abstract][Full Text] [Related]
7. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride.
Van Neste D
Skin Pharmacol Physiol; 2006; 19(3):168-76. PubMed ID: 16679818
[TBL] [Abstract][Full Text] [Related]
8. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
[TBL] [Abstract][Full Text] [Related]
9. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ; Dhurat RS
Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
[TBL] [Abstract][Full Text] [Related]
10. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
12. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
[TBL] [Abstract][Full Text] [Related]
13. Viable terminal scalp hair follicles constitute a necessary and sufficient biological end-organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles.
Van Neste D
Skin Res Technol; 2019 Sep; 25(5):701-711. PubMed ID: 31206839
[TBL] [Abstract][Full Text] [Related]
14. Expression of the L-fucose moiety on infrainfundibular follicular keratinocytes of terminal follicles, its decreased expression on vellus and indeterminate follicles of androgenetic alopecia, and re-expression in drug-induced hair regrowth.
Heng MC; Levine S; Fine H; Allen SG; Heng MK
J Invest Dermatol; 1992 Jan; 98(1):73-8. PubMed ID: 1370232
[TBL] [Abstract][Full Text] [Related]
15. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial.
Fischer TW; Burmeister G; Schmidt HW; Elsner P
Br J Dermatol; 2004 Feb; 150(2):341-5. PubMed ID: 14996107
[TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
17. Finasteride in the treatment of men with frontal male pattern hair loss.
Leyden J; Dunlap F; Miller B; Winters P; Lebwohl M; Hecker D; Kraus S; Baldwin H; Shalita A; Draelos Z; Markou M; Thiboutot D; Rapaport M; Kang S; Kelly T; Pariser D; Webster G; Hordinsky M; Rietschel R; Katz HI; Terranella L; Best S; Round E; Waldstreicher J
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):930-7. PubMed ID: 10365924
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.
Boersma IH; Oranje AP; Grimalt R; Iorizzo M; Piraccini BM; Verdonschot EH
Indian J Dermatol Venereol Leprol; 2014; 80(6):521-5. PubMed ID: 25382509
[TBL] [Abstract][Full Text] [Related]
19. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
Kaufman KD; Girman CJ; Round EM; Johnson-Levonas AO; Shah AK; Rotonda J
Eur J Dermatol; 2008; 18(4):407-11. PubMed ID: 18573713
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A; Godwin M
J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
